Theranostics 2022; 12(7):3575-3577. doi:10.7150/thno.72625 This issue

Erratum

A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions: Erratum

Jun Zhou1*, Menghuan Li1*, Wei Qi Lim2*, Zhong Luo1,3✉, Soo Zeng Fiona Phua2, Runlan Huo1, Liqi Li4, Ke Li3, Liangliang Dai3, Junjie Liu3, Kaiyong Cai3, Yanli Zhao2,5✉

1. School of Life Science, Chongqing University, Chongqing 400044, P. R. China;
2. Division of Chemistry and Biological Chemistry, School of Physical and Mathematical Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371;
3. Key Laboratory of Biorheological Science and Technology, Ministry of Education, Chongqing University, Chongqing 400044, P. R. China;
4. Department of General Surgery, Xinqiao Hospital, Third Military Medical University, Chongqing 400037, China;
5. School of Materials Science and Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798.
* These authors contributed equally to this work.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Zhou J, Li M, Lim WQ, Luo Z, Phua SZF, Huo R, Li L, Li K, Dai L, Liu J, Cai K, Zhao Y. A Transferrin-Conjugated Hollow Nanoplatform for Redox-Controlled and Targeted Chemotherapy of Tumor with Reduced Inflammatory Reactions: Erratum. Theranostics 2022; 12(7):3575-3577. doi:10.7150/thno.72625. Available from https://www.thno.org/v12p3575.htm

File import instruction

Corrected-article in Theranostics, Volume 8, 518